SEC Form 4 · accession 0001104659-18-002075
SUPERNUS PHARMACEUTICALS, INC. · SUPN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Gregory S Patrick
Officer — VP, Chief Financial Officer
Period of report
Jan 11, 2018
Accepted (ET)
Jan 12, 2018 · 4:32 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001356576
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Jan 11, 2018 | M | 25,000 | $5.88 | A | 55,975 | D | |
| Common Stock | Jan 11, 2018 | M | 20,000 | $7.90 | A | 75,975 | D | |
| Common Stock | Jan 11, 2018 | M | 30,000 | $9.24 | A | 105,975 | D | |
| Common StockF3 | Jan 11, 2018 | S | 50,000 | $43.5629 | D | 55,975 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F4 | $5.88 | Jan 11, 2018 | M | 25,000 | D | — | Dec 30, 2021 | Common Stock | 25,000 | 0 | D |
| Employee Stock Option (Right to Buy)F5 | $7.90 | Jan 11, 2018 | M | 20,000 | D | — | Feb 5, 2023 | Common Stock | 20,000 | 0 | D |
| Employee Stock Option (Right to Buy)F6 | $9.24 | Jan 11, 2018 | M | 30,000 | D | — | Jan 21, 2024 | Common Stock | 30,000 | 20,000 | D |
Explanation of responses
- F1Transaction made pursuant to a Rule 10b5-1 trading plan adopted December 12, 2017.
- F2Includes an aggregate of 259 shares acquired by the Reporting Person through the Issuer's Employee Stock Purchase Plan subsequent to the date of the Reporting Person's most recent filing on Form 4.
- F3The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.2500 to $43.8500, inclusive. The reporting person undertakes to provide to Supernus Pharmaceuticals, Inc. ("Supernus"), any security holder of Supernus, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4.
- F4The option became exercisable in four equal installments beginning on December 30, 2012, which was the first anniversary of the date on which the option was granted.
- F5The option became exercisable in four equal installments beginning on February 5, 2014, which was the first anniversary of the date on which the option was granted.
- F6The option became exercisable in four equal installments beginning on January 21, 2015, which was the first anniversary of the date on which the option was granted.